Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLDC

China Lending (CLDC) Stock Price, News & Analysis

About China Lending Stock (NASDAQ:CLDC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.04
$0.38
52-Week Range
N/A
Volume
N/A
Average Volume
127,460 shs
Market Capitalization
$253 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China Lending and its competitors with MarketBeat's FREE daily newsletter.

CLDC Stock News Headlines

Trump Makes Major Crypto Announcement
Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.
Central Asia's Debt Burden to China Examined
See More Headlines

CLDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that China Lending investors own include Apricus Biosciences (APRI), OncoCyte (OCX), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Gevo (GEVO), Arbutus Biopharma (ABUS) and Aurora Cannabis (ACBFF).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Miscellaneous Business Credit
Sub-Industry
N/A
Current Symbol
NASDAQ:CLDC
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$260 thousand
Price / Cash Flow
N/A
Book Value
($1.52) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$253 thousand
Optionable
Not Optionable
Beta
-0.22
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:CLDC) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners